Representation of Tene Investment Fund in a NIS 150 million acquisition of control in Sharon Laboratories Ltd.

October 2018

Our firm represented Tene Investment Fund in the NIS 150 million acquisition of control (60%) of the share capital of Sharon Laboratories Ltd., a global manufacturer and industry leader in the fields of development, production and marketing of preservatives for the food and cosmetics industries, which has shown constant growth in the past few years.

ene Investment Fund was represented by partner Lior Oren and attorneys Eyal Wiesel and Inna Gorin Ingram.

More Articles in Deals & Cases